Your browser doesn't support javascript.
loading
Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma.
Chen, Minjiang; Ma, Pengfei; Zhang, Yongchang; Wang, Dong; Yu, Zhuang; Fu, Yujie; Zhao, Xiaojing; Wang, Mengzhao; Zhuang, Guanglei; Jing, Ying.
Afiliação
  • Chen M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Ma P; State Key Laboratory of Systems Medicine for Cancer, Department of Thoracic Surgery, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang Y; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Wang D; Department of Orthopedics, Jiading District Anting Hospital of Shanghai, Shanghai, China.
  • Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Fu Y; State Key Laboratory of Systems Medicine for Cancer, Department of Thoracic Surgery, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhao X; State Key Laboratory of Systems Medicine for Cancer, Department of Thoracic Surgery, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China jingying@ipm-gba.org.cn zhuangguanglei@gmail.com mengzhaowang@sina.com.
  • Zhuang G; State Key Laboratory of Systems Medicine for Cancer, Department of Thoracic Surgery, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China jingying@ipm-gba.org.cn zhuangguanglei@gmail.com mengzhaowang@sina.com.
  • Jing Y; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Immunother Cancer ; 11(10)2023 10.
Article em En | MEDLINE | ID: mdl-37857527
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Carcinoma Pulmonar de Células não Pequenas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Doenças do Sistema Imunitário / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Carcinoma Pulmonar de Células não Pequenas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Doenças do Sistema Imunitário / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido